ResearcherIran University of Medical SciencesActive in the last 2 years

Fereshteh Rezagholizadeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-3407-3475; OpenAlex author ID A5032010044. Sources: OpenAlex.

Their work

Papers: 5 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2023: 1 paper · 2024: 3 papers · 2025: 1 paper

Papers 5

Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepitheli… Co-author DOI 10.1186/s12935-025-03810-1 ↗
Higher Expression of Talin-1 is Associated With Less Aggressive Tumor Behavior in Pancreatic Cancer. Co-author DOI 10.1097/pai.0000000000001220 ↗
High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Pathological Features in Patients with Pancreati… Co-author DOI 10.18502/ijaai.v23i3.15636 ↗
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2024.1283364 ↗
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma. First author DOI 10.1016/j.ctarc.2023.100699 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mohammad Taghi Joghataei · 3 shared papers, 2024–2025 · strength 0.65
Elahe Safari · 2 shared papers, 2024 · strength 0.43
- Paper High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Patholog… DOI 10.18502/ijaai.v23i3.15636 ↗
- Paper Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ducta… DOI 10.3389/fimmu.2024.1283364 ↗
Mahshid Panahi · 2 shared papers, 2023–2025 · strength 0.42
- Paper Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated p… DOI 10.1186/s12935-025-03810-1 ↗
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗
Pooya Farhangnia · 2 shared papers, 2023–2024 · strength 0.38
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗
- Paper Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ducta… DOI 10.3389/fimmu.2024.1283364 ↗
Samira Ahmadi Jazi · 1 shared paper, 2024 · strength 0.24
- Paper Higher Expression of Talin-1 is Associated With Less Aggressive Tumor Behavior in Pancreatic Cancer. DOI 10.1097/pai.0000000000001220 ↗
Zahra Madjd · 1 shared paper, 2024 · strength 0.24
- Paper Higher Expression of Talin-1 is Associated With Less Aggressive Tumor Behavior in Pancreatic Cancer. DOI 10.1097/pai.0000000000001220 ↗
Hamid Nickho · 1 shared paper, 2024 · strength 0.24
- Paper High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Patholog… DOI 10.18502/ijaai.v23i3.15636 ↗
Seyed Mohammad Heshmati · 1 shared paper, 2023 · strength 0.19
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.